KinCytE- a Kinase to Cytokine Explorer to Identify Molecular Regulators and Potential Therapeutic Opportunities
Marina ChaniD, Yuqi KangiD, Shannon Osborne, Michael A. ZageriD, Taranjit S. GujraliD
Abstract
Cytokines and chemokines are secreted proteins that regulate various biological processes, such as inflammation, immune response, and cell differentiation. Therefore, disruption of signaling pathways involving these proteins has been linked to a range of diseases, including cancer. However, targeting individual cytokines, chemokines, or their receptors is challenging due to their regulatory redundancy and incomplete understanding of their signaling networks. To transform these difficult-to-drug targets into a pharmacologically manageable class, we developed a web-based platform called KinCytE. This platform was designed to link the effects of kinase inhibitors, a well-established class of drugs, with cytokine and chemokine release and signaling networks. The resulting KinCytE platform enables users to investigate protein kinases that regulate specific cytokines or chemokines, generate a ranked list of FDA-approved kinase inhibitors that affect cytokine/chemokine activity, and explore and visualize cytokine signaling network thus facilitating drugging this challenging target class. KinCytE is freely accessible via https://atlas.fredhutch.org/kincyte.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.43
- Field percentile
- top 40%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CellEKT: A robust chemical proteomics workflow to profile cellular target engagement of kinase inhibitors
Joel Rüegger, Berend Gagestein, … Mario van der Stelt·Molecular & Cellular ProteomicsPeer-reviewed·Apr 6, 2025
- Kinome-centric pharmacoproteomics identifies signaling pathways underlying cellular responses to targeted cancer drugs
M. Golkowski, H.-T. Lau, … S.-E. Ong·bioRxiv·Nov 20, 2019
- Surveying the target tractability of cytokines with small molecules
Raavi, Sean P. Quinnell, … Arturo J. Vegas·bioRxiv·Apr 23, 2026
- Phosphoproteome profiling uncovers a key role for CDKs in TNF signaling
Maria C. Tanzer, Isabell Bludau, … Matthias Mann·Nature CommunicationsPeer-reviewed·Oct 18, 2021
- Rational design of chemically responsive cytokines for cancer immunotherapy
Lucia Bonati, Stephen Buckley, … Bruno E. Correia·bioRxiv·Sep 18, 2025
- Progress Towards a Public Chemogenomic Set for Protein Kinases and a Call for Contributions
D. H. Drewry, C. I. Wells, … T. M. Willson·bioRxiv·Jan 31, 2017